Loading program...
Loading program...
CQDM — Quebec Consortium for Drug Discovery
Funding for biopharmaceutical R&D
Funding and expert support for innovative translational R&D projects in biopharmaceutical research aimed at developing cutting-edge technologies that improve or accelerate drug discovery and development. Projects focus on delivering tangible results for large pharmaceutical companies and offer opportunities for future collaborations and licensing agreements with the biopharmaceutical industry.
Business Size: small, medium
Industries: biopharmaceutical
Region: Canada
Other Criteria: public research institutions, Canadian companies, undertake innovative translational R&D projects, in collaboration with large biopharmaceutical organizations, develop cutting-edge technologies with significant impact on R&D activities of CQDM biopharmaceutical members, focus on improving/accelerating drug discovery and development, generate tangible deliverables for CQDM pharmaceutical members, commitment from CQDM pharmaceutical members for around one-third (1/3) of the project's value, applicants are responsible for raising necessary counterpart funds
Preview of what's included with full access:
Everything you need to submit a winning application
What's included
“Saved me several hours of research”
— New Business Owner, Vancouver
Government of Ontario, Ontario Centre of Innovation
Funding for Intellectual Property collaborations
Government of Alberta, Alberta Innovates
Voucher for advanced stage development in Alberta
Government of Canada, Innovation, Science and Economic Development Canada
Personalized advisory services for innovators in British Columbia
This program is available to small, medium businesses in biopharmaceutical industries located in Canada.
This program offers funding up to $1,500,000 (minimum $500,000).
The application deadline is May 14, 2026.
30-day guarantee · Secure checkout · Prices in CAD · No annual lock-in
“Saved me several hours of research” — New Business Owner, Vancouver